Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients (RAND)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01195818
First received: September 3, 2010
Last updated: June 17, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)